Lachowiez CA, Reville PK, Kantarjian H, Jabbour E, et al. Contemporary outcomes in IDH-mutated AML: The impact of co-occurring NPM1 mutations and venetoclax-based treatment. Am J Hematol 2022 Aug 22. doi: 10.1002/ajh.26694.
PMID: 36054614